SCHEDULE 13G/A: ARK Investment Management Discloses 10.75% Passive Stake in Personalis, Inc.

ARK Investment Management LLC has reported a 10.75% beneficial ownership stake in Personalis, Inc., holding 7,085,523 shares of common stock as of September 30, 2024.

Summary

• ARK Investment Management LLC filed an Amendment No. 5 to Schedule 13G regarding its beneficial ownership in Personalis, Inc.
• As of September 30, 2024, ARK Investment Management LLC beneficially owns 7,085,523 shares of Personalis, Inc. Common Stock.
• This ownership represents 10.75% of the total class of securities.
• ARK Investment Management LLC holds sole voting power and sole dispositive power over all 7,085,523 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: The disclosure of a significant passive stake by a well-known institutional investor like ARK Investment Management is generally viewed positively as it indicates confidence in the company. However, it provides no new operational or financial performance data.

Positives

• A significant institutional investor, ARK Investment Management LLC, holds a substantial stake (10.75%) in Personalis, Inc., which may indicate confidence in the company's long-term prospects.
• The filing confirms the stake is passive, suggesting it is an investment rather than an attempt to influence control, which can be viewed positively by the market.

Future Outlook

This Schedule 13G filing does not provide forward-looking statements or guidance regarding Personalis, Inc.'s future performance or ARK Investment Management LLC's investment strategy beyond the passive nature of the reported stake.

Management Comments

• The filing includes a certification from ARK Investment Management LLC stating that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing indicates a significant investment by a prominent asset manager known for its focus on disruptive innovation, particularly in sectors like genomics and biotechnology, where Personalis, Inc. operates. Such an investment by ARK could signal their belief in the long-term growth potential within the precision medicine and advanced diagnostics industry.

Comparison to Industry Standards

• As a Schedule 13G filing, this document primarily reports a passive ownership stake and does not contain performance metrics for direct comparison to industry standards or specific comparable companies. The significance lies in the identity of the investor and the size of the stake within the biotechnology and genomics sector.

Stakeholder Impact

• Shareholders: May view the significant stake by ARK Investment Management as a positive signal, potentially increasing investor confidence.
• Company Management: Awareness of a large institutional holder may influence strategic decisions, though the stake is declared passive.

Key Dates

Keywords

Personalis Inc., ARK Investment Management, Schedule 13G, beneficial ownership, common stock, institutional investment, genomics, precision medicine, biotechnology